What Is CRL Fair Value?
Charles River Laboratories (CRL) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Charles River Laboratories (CRL) has a composite fair value estimate of $145.32 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $299.02, suggesting the stock is overvalued by 51.4%.
Data as of October 14, 2026 (today)
Composite Fair Value
Overvalued3 of 4 models$145.32
vs. current price of $299.02(-51.4%)
How Is CRL Fair Value Calculated?
Four independent models estimate what CRL is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CRL Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
41% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$145.90
-51.2%Overvalued
Inputs used
DDM (Dividend Discount Model)
0% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
N/A
This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.
CRL Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
29% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$123.38
-58.7%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
29% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$130.38
-56.4%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $299.02 is 51.2% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $522.6M | $471.8M |
| Year 2 | $582.5M | $474.7M |
| Year 3 | $649.3M | $477.7M |
| Year 4 | $723.8M | $480.7M |
| Year 5 | $806.7M | $483.7M |
| Year 6 | $899.2M | $486.7M |
| Year 7 | $1.00B | $489.8M |
| Year 8 | $1.12B | $492.8M |
| Year 9 | $1.25B | $495.9M |
| Year 10 | $1.39B | $499.0M |
| Terminal Value | $17.20B | $6.18B |
What Are CRL's Key Financial Metrics?
Earnings & Growth
Current Price
$299.02
EPS (TTM)
-$4.80
Forward P/E
23.4
Profit Margin
-6.0%
Cash & Balance Sheet
Free Cash Flow
468.9M
EBITDA
849.1M
Book Value
$59.50
Total Debt
3B
What Do Analysts Say About CRL?
Low
$145.00
Average
$313.20
High
$357.00
Upside
+4.7%
CRL Fair Value FAQ
What is the fair value of CRL?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CRL's estimated fair value is $145.32. The stock is currently trading at $299.02, which makes it overvalued by our analysis.
How is CRL's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CRL overvalued or undervalued?
Based on our analysis, CRL is overvalued. The current price of $299.02 is 51.4% above our estimated fair value of $145.32.
What do Wall Street analysts say about CRL?
15 analysts cover Charles River Laboratories with a consensus rating of "Buy." The average price target is $313.20, ranging from $145.00 to $357.00. This implies 4.7% upside from the current price.